OSRHOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as OSRHW
OSR Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.21−0.02 (-7.08%)
Close on Oct 19, 2026
- Market cap
- $6.83M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.3653 (−63.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
OSR Health, Inc. saw revenue fall 50.2% to $1.81M over the twelve months to Jun 30, 2026.
Revenue
$1.81M
-50.2% vs. a year earlier
Operating income
-$16.89M
TTM Q2 2026
EPS, diluted
-$0.80
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $6.83M
- P/E ratio
- –
- Price to sales
- 3.77
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.81M
- EPS, diluted
- -$0.80
- Diluted shares
- 33M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$1.81M-50.2% YoY
Gross profit
$638.32K+18.1% YoY
Operating income
-$16.89M
Net income
–
EPS, diluted
–
Reported periodTrailing twelve months